- Home
- NPCE
NPCE
Neuropace Inc.
as 04-01-2025 3:40pm EST
| Founded: | 1997 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $14.83 | AVG Volume (30 days): | 221.7K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.45 - $15.78 | Next Earning Date: | 03-04-2025 |
| Revenue: | $79,906,000 | Revenue Growth: | 22.14% |
| Revenue Growth (this year): | 18.67% | Revenue Growth (next year): | 19.78% |
Stock Insider Trading Activity of Neuropace Inc. (NPCE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Morrell Martha | NPCE | CHIEF MEDICAL OFFICER | Feb 21 '25 | Sell | $13.72 | 78,334 | $1,074,844.31 | 81,993 | |
| KCK LTD. | NPCE | 10% Owner | Feb 20 '25 | Sell | $9.40 | 5,270,845 | $49,545,943.00 | 0 | |
| Morrell Martha | NPCE | CHIEF MEDICAL OFFICER | Jan 29 '25 | Sell | $15.00 | 300 | $4,500.00 | 81,993 | |
| Morrell Martha | NPCE | CHIEF MEDICAL OFFICER | Jan 24 '25 | Sell | $15.01 | 3,200 | $48,032.00 | 81,993 |
Latest Neuropace Inc. News
NPCE Breaking Stock News: Dive into NPCE Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
Simply Wall St.
a month ago
NeuroPace Full Year 2024 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
a month ago
Q4 2024 Neuropace Inc Earnings Call
GuruFocus.com
a month ago
NeuroPace Inc (NPCE) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Associated Press Finance
a month ago
NeuroPace Inc.: Q4 Earnings Snapshot
GlobeNewswire
a month ago
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
a month ago
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
GlobeNewswire
a month ago
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
Compare NPCE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NPCE Neuropace Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.